Ardelyx | ARDX - Cost Of Sales

Stock Price
5.41
Daily Change
-0.15 -2.61%
Monthly
-5.67%
Yearly
-1.55%
Q1 Forecast
5.61

Ardelyx reported $10.85M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
Amgen USD 1.79B 128M Dec/2025
Ardelyx USD 10.85M 6.87M Dec/2025
aTyr Pharma USD 3.34M 18.79M Dec/2025
Corcept Therapeutics USD 2.54M 2.05M Dec/2025
Curis USD 10.27M 610K Jun/2024
Sanofi EUR 3.76B 344M Dec/2025
TG Therapeutics USD 38.14M 10.05M Dec/2025
United Therapeutics USD 474.7M 373.8M Dec/2025
Xoma 116K 112.7K Jun/2024